Local News

• Boston Scientific announces program to analyze Latitude(R) patient monitoring data  Boston Scientific announced a new clinical science initiative, ALTITUDE, which will analyze data from the LATITUDE Patient Management system. The initiative will seek answers to questions related to implantable cardiac defibrillator and cardiac resynchronization therapy defibrillator device therapy.
  Boston Scientific Corporation May 15, 2008  
• Wyeth's major depressive disorder treatment Pristiq now available in U.S. pharmacies  Wyeth Pharmaceuticals announced that PRISTIQ(TM), a new serotonin-norepinephrine reuptake inhibitor approved to treat adult patients with major depressive disorder, is now available in U.S. retail pharmacies nationwide. The recommended dose of PRISTIQ is 50 milligrams (mg) once daily.
  Wyeth May 15, 2008  
• FDA approves AstraZeneca’s Seroquel for maintenance treatment in bipolar disorder  AstraZeneca announced that the U.S. Food and Drug Administration has approved SEROQUEL(R) (quetiapine fumarate) for the maintenance treatment of patients with bipolar I disorder, as adjunct to lithium or divalproex.
  AstraZeneca May 14, 2008  
• DuPont and Genencor create world-leading cellulosic ethanol company  DuPont and Genencor announced an agreement to form DuPont Danisco Cellulosic Ethanol, a 50/50 global joint venture to develop and commercialize the leading, low-cost technology solution for the production of cellulosic ethanol to address a $75 billion global market opportunity.
  Genencor May 14, 2008  
• Clinical Data launches genetic test for hypertrophic cardiomyopathy  Clinical Data announced at the Heart Rhythm Society's annual meeting, 2008 Heart Rhythm, that its PGxHealth(TM) division is adding genetic testing for Hypertrophic Cardiomyopathy (HCM) to its FAMILION(R) family of genetic tests for cardiac syndromes.
  Clinical Data, Inc. May 14, 2008  
• Cynosure appoints H. Travis Lee as Vice President of Global Marketing  Cynosure announced the appointment of H. Travis Lee as vice president of global marketing. Lee will develop and implement worldwide strategic marketing initiatives for all of Cynosure's flagship products, including the Smartlipo MPX, the company's newest system for laser lipolysis.
  Cynosure, Inc. May 14, 2008  
• F.D.A. chief writes Congress for money  After being pummeled for weeks on Capitol Hill over the president's budget, Food and Drug Commissioner Andrew C. von Eschenbach has written Congress that the agency needs an immediate infusion of $275 million to ensure that imported foods, drugs and medical devices are safe.
  The New York Times May 14, 2008  Gardiner Harris
• Lilly employees from nearly 50 nations participate in first-ever Global Day of Service  Thousands of Eli Lilly and Company employees in nearly 50 nations are rolling up their sleeves to help address local community needs in celebration of Lilly's first-ever Global Day of Service, possibly the largest corporate volunteer initiative to ever take place on one day.
  Eli Lilly and Company May 14, 2008  
• BioLife Solutions announces FDA Master File Acceptance for CryoStor™  BioLife Solutions, a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced that its Master File for CryoStor cryopreservation media has been accepted by the US Food and Drug Administration (FDA).
  BioLife Solutions Inc. May 14, 2008  
• Merck wins appeal in VIOXX(R) case  Merck & Co. said a Texas appellate court overturned the April 2006 verdict of a state court jury in Starr County, Texas, in the VIOXX product liability case Garza v. Merck. The Texas Fourth Court of Appeals reversed the jury's verdict and rendered a judgment in favor of Merck.
  Merck & Co., Inc. May 14, 2008  

   (next 10 articles)